BIRMINGHAM ? Healthcare management company ChangeScape has added two principals, project management expert Larry Lacombe and healthcare information technology executive J. Paul Solverson. Both will help ChangeScape in its efforts to develop a regional health information organization for Michigan that could serve as a national model. Lacombe comes to ChangeScape from The PCI Group, a
DETROIT ? Tissue bank company Asterand has rolled out a cell line that offers researchers an important tool in the study of breast cancer. The cell line, known as MCF10DCIS.com, will be valuable for the testing of chemopreventive agents and for screening cancer causing agents, in addition to screening anticancer drugs. "MCF10DCIS.com is one of
ANN ARBOR ? Human tissue repair start up Aastrom Biosciences lost more than $5 million in the third quarter ended March 31, on revenue of just $238,000. For the first nine months of the fiscal year, Aastrom lost $13.5 million, while earning just $535,000, primarily from grant revenues, rather than product sales. The company did
ANN ARBOR - Life sciences trade association MichBio has disclosed more details about its October MichBio Expo 2006, a three-day series of meetings, lectures, exhibits and student-focused career events that will be held in Grand Rapids at the DeVos Place convention center. MichBio expects the Expo to attract 800 participants from across the state to
GRAND RAPIDS - Van Andel Research Institute Director George Vande Woude has been elected a fellow of the American Academy of Arts and Sciences. One of the world?s most renowned experts in molecular oncology, Vande Woude was appointed as the inaugural director of VARI in 1999 following a 28-year tenure with the National Cancer Institute
ANN ARBOR - Future Innovations in Eye Care will be the topic of the next quarterly Sprouts meeting April 25 at Ann Arbor SPARK, the former IT Zone Launch pad in downtown Ann Arbor. Keynote speaker is Brian Levy, vice president and chief medical officer of Bausch & Lomb. Also discussing this topic will be
ANN ARBOR ? Aastrom Biosciences last week said it sold $25.5 million in common stock to a select group of institutional investors. The proceeds will be ussed to fund clinical trials, manufacturing development, and provide working capital, the company said in a statement filed with the U.S. Securities and Exchange Commission. The offering was for
GRAND RAPIDS ? The Van Andel Institute, a MichBio member, on Monday named Steven Triezenberg, Ph.D. as the founding dean of the Van Andel Education Institute Graduate School. Triezenberg, who currently serves as associate director of Michigan State University's cell and molecular biology graduate program, will help develop VAEI's doctoral program in cellular and molecular
YPSILANTI - Ed Pagani, president of MichBio, urged Michigan?s elected officials to use the 21st Century Jobs Fund wisely to invest in companies that could continue to build the Life Sciences Corridor. His full remarks follow: Good evening, and welcome to the MichBio Annual Meeting. We have a very full program tonight, and in the
YPSILANTI - More than 150 people jammed into a crowded hall at the Eagle Crest Conference Center last week to attend the 2006 MichBio Annual Meeting, making it the best attended annual meeting in the Michigan life sciences trade association's history. But one MichBio officer who spoke warned unless Michigan uses its scarce dollars wisely,